The Latest Cardiac and Vascular News
EchoGo® Heart Failure revolutionizes the detection of HFpEF – the biggest unmet need in cardiovascular medicine.1 OXFORD, England, Dec. 6, 2022 /PRNewswire/ — Ultromics’ EchoGo® Heart Failure, an AI solution for echocardiography with the potential to revolutionize the diagnosis of heart failure with preserved ejection fraction (HFpEF), has received US Food and Drug […]
The FNIH’s Accelerating Medicines Partnership® Heart Failure OXFORD, England, Sept. 29, 2022 /PRNewswire/ — Ultromics, a digital health technology company pioneering the development of transformative heart failure diagnostics, has joined as a full partner The Accelerating Medicines Partnership® Heart Failure (AMP® HF) including the National Institutes of Health (NIH) and the National Heart Lung and Blood Institute (NHLBI), managed […]
Collaboration will empower clinicians with AI-enhanced diagnostics for heart failure and coronary artery disease beyond the walls of the hospital BRISBANE, Calif., OXFORD, England and GUILFORD, Conn., Nov. 9, 2021 /PRNewswire/ — Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced a strategic partnership to accelerate cardiovascular disease detection […]
Led by Blue Venture Fund, new funding will accelerate Ultromics’ use of AI-enabled echocardiograms to improve patient outcomes OXFORD, England, Aug. 16, 2021 /PRNewswire/ — Ultromics, a leader in AI enabled cardiovascular imaging solutions, announced today that it has raised $33 million in a Series B funding round. The round was led by the […]
EchoGo Pro is an AI service for automated identification of coronary artery disease – FDA gives 510(K) clearance for EchoGo Pro, expanding the use of Ultromics’ EchoGo service to support clinicians diagnosing coronary artery disease – Every year in the U.S. over 800,000 people die from heart disease – accounting […]
The SaaS suite helps physicians automate key measurements and predict the occurrence of CAD, enabling clinicians to proactively recommend preventive actions that improve patient outcomes LONDON, Sept. 24, 2020 /PRNewswire/ — Based on its recent analysis of the global AI-based echocardiography market, Frost & Sullivan recognizes Ultromics with the 2020 Global New Product Innovation Award […]
NEWARK, Del., Sept. 22, 2020 /PRNewswire/ — Laurel Bridge Software, a provider of software solutions that enable healthcare organizations to orchestrate their medical imaging workflows, announces a new partnership with Ultromics, a global health technology firm, which provides autonomous echocardiography analysis through innovative AI solutions. The Laurel Bridge AI Workflow Suite (AIWS) enables the Ultromics EchoGo suite of cloud-based AI […]
AI automates cardiac analysis helping earlier detection of cardiovascular disease, enabling clinicians to improve patient care and outcomes OXFORD, England, Nov. 14, 2019 /PRNewswire/ — Ultromics, the UK-based health technology firm at the forefront of applying artificial intelligence to echocardiography, has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for […]
